SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Collage illustration showing contract being reviewed and someone working on a computer
Job Trends
The Right Fit: Contract Work Finds Increasing Favor Among Employers, Professionals
Contract work opportunities have grown year over year, and recent reports show more people are in this type of role, according to BioSpace data. Three biopharma professionals share why they’ve become contractors and discuss the pros and cons.
February 26, 2026
 · 
6 min read
 · 
Angela Gabriel
Illustration showing robot hand touching human hand
Career Advice
AI Tips and Prompts That Can Take Your Job Search to the Next Level
While you should never rely solely on AI tools when applying for jobs, they can greatly benefit the application process. Recruiting expert Bryan Blair discusses how using large language models can set you apart from the competition and includes a prompt framework to get you started.

February 26, 2026
 · 
8 min read
 · 
Bryan Blair
Negative emotion image. Person head shaped paper on black torn paper background.
Opinion
New Painkillers Critical To Fight Opioid Epidemic, Broader Pain Crisis
Alternatives to opioids are desperately needed to better treat moderate to severe acute pain, but to date, we’ve seen few novel analgesics hit the market.
February 26, 2026
 · 
6 min read
 · 
James Hackworth
New Opportunity, Businessman Walks Up Stairs Finds Exit Big Door
C-suite
Sarepta CEO Doug Ingram To Step Down as Muscular Dystrophy Mission Hits Home
When Ingram became Sarepta Therapeutics’ CEO in 2017, he didn’t have a connection to muscular dystrophy, but he has developed a fierce passion for the therapeutic area. He will step aside from his role to dedicate more time to his family.
February 25, 2026
 · 
2 min read
 · 
Annalee Armstrong
Aerial photo hotels in Denton, Texas
Manufacturing
Novartis Names Texas City as Location of Its 5th US Radiopharmaceutical Facility
The Denton site is part of a network of manufacturing plants Novartis is building across the U.S. to make cancer drugs that must be shipped to patients quickly.
February 25, 2026
 · 
2 min read
 · 
Nick Paul Taylor
A pill bottle in between two injector pens
Weight loss
Novo Leans Into Oral Route With Weight Loss Partnership Worth up to $2.1B
After its next-generation obesity asset CagriSema lost a head-to-head matchup with Eli Lilly’s Zepbound, Novo Nordisk is throwing more money into the obesity space, striking a deal with Vivtex to advance novel weight loss pills.
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac
President Donald Trump calls out the first patient to access his TrumpRx drug platform during his State of the Union address at the U.S. Capitol on Tuesday, February 24, 2026.
Drug pricing
Trump Calls on Congress To Codify Most Favored Nation Drug Pricing in SOTU
In his State of the Union address on Tuesday evening, President Donald Trump urged Republican leaders to pass legislation cementing his new drug pricing initiatives as he touted his efforts to lower healthcare costs for Americans.
February 25, 2026
 · 
2 min read
 · 
Annalee Armstrong
The white plane flies against the blue sky, leaving a white trail. Vector illustration
Vaccines
Postponed ACIP Meeting Rescheduled for Mid-March
The rescheduling of the Advisory Committee on Immunization Practices comes amid fresh leadership upheaval at the CDC as NIH director Jay Bhattacharya replaces Jim O’Neill as acting head of the agency.
February 25, 2026
 · 
3 min read
 · 
Tristan Manalac
Dollar boat swimming on paper waves
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
Solstice Oncology will gain an exclusive worldwide license to Harbour BioMed’s porustobrt, an anti-CTLA-4 antibody currently being studied for melanoma, colorectal cancer and other malignancies in China.
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS